Bladder cancer surgery: new model aims to predict recurrence risk
NCT ID NCT07589413
First seen May 17, 2026 · Last updated May 17, 2026
Summary
This study looks at 150 people having bladder tumor surgery to see if the amount of fluid absorbed during the procedure and changes in DNA fragments in the blood can help predict if the cancer will come back or spread. Researchers will collect blood samples before and after surgery and track patients over time. The goal is to improve how doctors assess risk and plan follow-up care after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Hospital of Lanzhou University
RECRUITINGLanzhou, Gansu, 730030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.